BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23038032)

  • 1. Choice of artificial tear formulation for patients with dry eye: where do we start?
    Tong L; Petznick A; Lee S; Tan J
    Cornea; 2012 Nov; 31 Suppl 1():S32-6. PubMed ID: 23038032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of lubricating eye drop containing hydroxypropyl guar on perimetry results of patients with glaucoma and trachomatous dry eye.
    Guzey M; Satici A; Karaman SK; Sezer S; Bozkurt O
    Ophthalmologica; 2010; 224(2):109-15. PubMed ID: 19729983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, double-blind, parallel group, placebo-controlled clinical study to examine the safety and efficacy of T-Clair SPHP700-3 in the management of mild to moderate dry eye in adults.
    Villani E; Laganovska G; Viola F; Pirondini C; Baumane K; Radecka L; Ratiglia R
    Cornea; 2011 Mar; 30(3):265-8. PubMed ID: 21099417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion.
    Asbell PA
    Curr Med Res Opin; 2006 Nov; 22(11):2149-57. PubMed ID: 17076975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there an universal artificial tear?].
    Turu L
    Oftalmologia; 2012; 56(1):14-9. PubMed ID: 22888681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness.
    Scaffidi RC; Korb DR
    Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and use of tear film evaluation tests by spanish practitioners.
    Cardona G; Serés C; Quevedo L; Augé M
    Optom Vis Sci; 2011 Sep; 88(9):1106-11. PubMed ID: 21642888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye.
    Springs CL
    Adv Ther; 2010 Oct; 27(10):681-90. PubMed ID: 20803266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
    Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA; Goto E; Tseng SC
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.
    Ribeiro MVMR; Barbosa FT; Ribeiro LEF; Sousa-Rodrigues CF; Ribeiro EAN
    Arq Bras Oftalmol; 2019 Sep; 82(5):436-445. PubMed ID: 31508669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical evaluation of Systane.
    Gifford P; Evans BJ; Morris J
    Cont Lens Anterior Eye; 2006 Mar; 29(1):31-40. PubMed ID: 16473547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye.
    Khanal S; Tomlinson A; Pearce EI; Simmons PA
    Cornea; 2007 Feb; 26(2):175-81. PubMed ID: 17251808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
    Pokupec R; Petricek I; Sikić J; Bradić M; Popović-Suić S; Petricek G
    Acta Med Croatica; 2005; 59(4):337-40. PubMed ID: 16334742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ocular aberrations after instillation of artificial tears in dry-eye patients.
    Montés-Micó R; Cáliz A; Alió JL
    J Cataract Refract Surg; 2004 Aug; 30(8):1649-52. PubMed ID: 15313286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative treatment of dry eye].
    Hefner J; Reinshagen H
    Klin Monbl Augenheilkd; 2014 Nov; 231(11):1093-6. PubMed ID: 25275793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.